About Dr. Patrick Soon-Shiong
Dr. Patrick Soon-Shiong a physician, surgeon and scientist, has pioneered novel therapies for both diabetes and cancer, published over 100 scientific papers, and has over 170 issued patents worldwide on groundbreaking advancements spanning myriad fields of technology and medicine.
Dr. Soon-Shiong serves as Chairman of the Chan Soon-Shiong Family Foundation and Chairman and CEO of the Chan Soon-Shiong Institute of Molecular Medicine, a non-profit medical research organization and Chairman and CEO of NantKwest, a Nasdaq listed immunotherapy company focusing on Natural Killer cells. He currently co-chairs the CEO Council for Health and Innovation at the Bipartisan Policy Center and is a member of the Global Advisory Board of Bank of America. He is an Adjunct Professor of Surgery at UCLA, and a visiting Professor at the Imperial College of London and Dartmouth College. The Friends of the National Library of Medicine has honored him with their Distinguished Medical Science Award, he was the Ellis Island Medal of Honor Award Recipient, and the recipient of the Gilda’s Club New York City Award for the Advancement of Cancer Medicine.
In 2016 he launched Cancer Moonshot 2020 a coalition of biotech, pharma, academia, community oncologists, payers and government agencies committed to accelerating next generation sequencing, proteomics, big data analytics and immunotherapy drug development for all cancer types.
Dr. Soon-Shiong performed the world’s first encapsulated human islet transplant, the first engineered islet cell transplant and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nation’s first FDA approved protein nanoparticle albumin-bound delivery technology for the treatment of cancer. Abraxane was approved by the FDA for metastatic breast cancer in 2005, lung cancer in 2012, and pancreatic cancer in 2013. The drug is approved in the U.S. and E.U. for metastatic breast cancer, lung cancer and advanced pancreatic cancer, making it the only drug of its kind to be approved in first line therapies across this broad spectrum of tumors in both the US and EU.
From 1997 to 2010 Dr. Soon-Shiong has served as founder, Chairman and CEO of two global pharmaceutical companies, American Pharmaceutical Partners and Abraxis BioScience. Both were acquired for multi-billion dollars in 2008 and 2010. In 2011 he founded NantWorks, an ecosystem of companies to create a transformative global health information and next generation pharmaceutical development network. In 2015 he initiated the public offering of NantKwest, setting a record when trading opened on Nasdaq as the largest biotech IPO by market cap in history. In 2016, he received the Franklin Bower Award for Business Leadership from The Franklin Institute.
Last Updated April 2016
Dr. Patrick Soon-Shiong Keynotes at NHS Confederation Annual Conference and Exhibition
Clinton Foundation Health Matters Conference 2014
The 2014 Health Matters: Activating Wellness in Every Generation Conference took place in La Quinta, California, on January 13-15. The conference announced 30 new strategic partnerships and reached more than 30.7 million users across Facebook and Twitter, trended #1 on Twitter in the U.S. during the conference, and garnered more than 72,500 views on Livestream.
The Role of Proteomics in Finding a Cure for Cancer
CEO Council on Health and Innovation
The United States spends more on health care per capita than any other nation in the world, and yet its citizens are not the world’s healthiest. The vast majority of U.S. health care spending—an estimated 84 percent—is associated with chronic diseases and conditions such as diabetes and heart disease.
The human costs of an unhealthy population are significant, and so is the economic impact. Some experts estimate that an unhealthy workforce costs U.S. employers $576 billion annually due to lost productivity, health care costs, and wage replacement.2 This threatens the nation’s ability to compete with strength in the global marketplace. Employers have increasingly recognized this fact, as well as the potential they hold to influence the health of the nation.
Employers can have a powerful impact on helping individuals and communities develop and/or maintain healthy habits that can improve health or better manage chronic conditions. The organizations represented on the CEO Council are leading the way toward a new understanding of health and health care, and a new vision of a health care system in which everyone plays an important role. Together they represent nearly one million members of the U.S. workforce and 104 million “covered lives” (e.g., employees, their families, and retirees covered by health insurance). Their impact is broader than this, however, through programs that promote health and wellness in the communities they serve.
These organizations are successful in the marketplace because they recognize and pursue the power of innovation in developing and delivering products and services, managing their organizations, and meeting the needs of their customers. They bring this same innovative approach to improving and supporting the health and wellness of their workforces, developing creative strategies, and employing best practices. Through this Council, these companies are sharing their health strategies and best practices in order to highlight and spread successful initiatives to other organizations.
Goals of the CEO Council
The goals of the CEO Council on Health and Innovation are to:
- Share innovative strategies and best practices that Council members are using to promote health and wellness and improve the quality, cost-effectiveness, and patient experience of care;
- Encourage other employers to implement strategies that will improve health and health care in the United States; and
- Promote learning and improvement by tracking and sharing outcomes and best practices.
CEO Council members are focused on advancing innovative strategies that fall into three pillars:
1. Those that improve the health and wellness of individuals (e.g., employees, their families, and retirees);
2. Those that improve the health of the communities; and
3. Those that improve the health care system.
A Health Care Advisory Board, made up of chief executives of organizations representing clinicians, consumers, and hospitals, is providing expert guidance in this collaborative effort. In addition, former U.S. Senate Majority Leaders and Co-chairs of BPC’s Health Project Tom Daschle (D-SD) and Bill Frist (R-TN) are advising the Council, along with Janet Marchibroda, BPC’s director of Health Innovation, who serves as the Council’s executive director.
Chan Soon-Shiong Institute for Advanced Health (IAH)
The Chan Soon-Shiong Institute for Advanced Health (IAH) is a 501c(3) nonprofit medical research organization focused on changing the way health information is shared. Established in 2011, IAH received core funding from Dr. Patrick Soon-Shiong and his wife Michele B. Chan, who have pledged through their family foundation more than $1 billion for health care and health information projects.
The Giving Pledge by Michele B. Chan and Patrick Soon-Shiong
Martin Luther King Jr./Charles R. Drew Medical Center
Billionaire offers $100-million guaranty to reopen King hospital
The funding from Patrick Soon-Shiong's family foundation would underwrite a University of California effort to resuscitate the medical center near Watts.
Los Angeles pharmaceutical billionaire Patrick Soon-Shiong announced plans Wednesday to provide University of California regents with a $100-million guaranty underwriting the county's latest proposal to reopen long-troubled Martin Luther King Jr.-Harbor Hospital by 2012.
County officials have expressed misgivings about Soon-Shiong's efforts to reopen the hospital in the past. But he said the funding from his family foundation comes "with no strings attached" and is intended to reassure university officials hesitant to reopen the hospital.
"This could be the county hospital of the future," said Soon-Shiong, 57, a former UCLA surgeon.
For the full report, click here.
- CNBC (10/05/09) - Billionaire Doctor Puts His Money Where His Mind Is
- Los Angeles Times (11/20/09) - UC regents approve partnership with L.A. County to reopen King medical facility
- Los Angeles Times (11/22/09) - A doctor without borders
- Huffington Post (03/18/2010) - Let the New Partnership Begin
Pharmaceutical executive donates $100 million to St. John's Health Center
The gift from Patrick Soon-Shiong and his wife is aimed at turning St. John's into a cutting-edge medical hub.
A billionaire Los Angeles pharmaceutical executive bent on creating a national medical data-sharing network has donated $100 million to turn St. John's Health Center in Santa Monica into a cutting-edge hub.
The gift from Patrick Soon-Shiong, founder and chief executive of Los Angeles-based Abraxis BioScience Inc., and his wife, Michele Chan, a former actress, is the hospital's largest donation by an individual and one of the largest received by a community hospital in California. It comes on top of an additional $35 million the couple donated to the hospital two years ago.
About $35 million has been spent on the expanded and renovated 380-bed hospital, and $10 million more to attract doctors and scientists. That leaves $55 million to create several research centers and fund future projects, said St. John's Chief Executive Lou Lazatin.
"It will make St. John's the community hospital of the future," Lazatin said.
For the full report, click here.
Saint John's Health Center
Abraxis CEO, Wife to Give St. John's $35 Million
Santa Monica, CA -- January 15, 2007 -- Saint John's Health Center announced today that in recognition of its outstanding patient care and its commitment to translational medicine, Michele B. Chan, Dr. Patrick Soon-Shiong, and their family have committed $35 million to complete the building of a world class inpatient life science center, and to begin development of a new Center for Translational Sciences. Dr. Soon-Shiong is the founder, president and chief executive officer of Abraxis BioScience.
The Health Center is naming the state-of-the-art inpatient facility the Chan Soon-Shiong Center for Life Sciences, to honor a $25 million grant to Saint John's Challenge to Lead Campaign. An additional $10 million grant will be designated to develop a master plan for its South Campus and the Chan Soon-Shiong Center for Translational Sciences, which will be developed subject to requisite approvals.